APA (7th ed.) Citation

Harvey, J. P., Raymakers, A. J. N., Rand, L. Z., Goshua, G., Kesselheim, A. S., & Pandya, A. (2026). Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid Programs. JGIM: Journal of General Internal Medicine, 41(4), 1185. https://doi.org/10.1007/s11606-025-09865-0

Chicago Style (17th ed.) Citation

Harvey, Jessica Preston, Adam J. N. Raymakers, Leah Z. Rand, George Goshua, Aaron S. Kesselheim, and Ankur Pandya. "Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid Programs." JGIM: Journal of General Internal Medicine 41, no. 4 (2026): 1185. https://doi.org/10.1007/s11606-025-09865-0.

MLA (9th ed.) Citation

Harvey, Jessica Preston, et al. "Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid Programs." JGIM: Journal of General Internal Medicine, vol. 41, no. 4, 2026, p. 1185, https://doi.org/10.1007/s11606-025-09865-0.